KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 155 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,593 | -6.0% | 40,741 | +138.5% | 0.01% | -36.8% |
| Q4 2022 | $58,079 | +81.5% | 17,082 | +188.8% | 0.02% | +18.8% |
| Q3 2022 | $32,000 | -33.3% | 5,914 | -44.2% | 0.02% | -46.7% |
| Q2 2022 | $48,000 | -56.8% | 10,606 | -29.8% | 0.03% | -46.4% |
| Q1 2022 | $111,000 | +19.4% | 15,116 | +4.8% | 0.06% | +30.2% |
| Q4 2021 | $93,000 | +17.7% | 14,427 | +6.9% | 0.04% | -15.7% |
| Q3 2021 | $79,000 | -47.0% | 13,502 | -6.3% | 0.05% | -45.7% |
| Q2 2021 | $149,000 | – | 14,403 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 3,561,052 | $26,245,000 | 5.86% |
| Palo Alto Investors LP | 5,621,533 | $41,431,000 | 3.20% |
| Iron Triangle Partners LP | 2,000,000 | $14,740,000 | 1.75% |
| Altium Capital Management LP | 645,000 | $4,754,000 | 1.59% |
| Birchview Capital, LP | 269,332 | $1,985,000 | 1.43% |
| Rubric Capital Management LP | 3,607,443 | $26,587,000 | 0.96% |
| Lombard Odier Asset Management (Switzerland) SA | 776,053 | $5,720,000 | 0.45% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,344,929 | $9,912,000 | 0.40% |
| Golden State Equity Partners | 41,850 | $308,000 | 0.16% |
| Hennion & Walsh Asset Management, Inc. | 385,837 | $2,844,000 | 0.15% |